Avalo Therapeutics CFO Christopher Ryan Sullivan disposes of common shares worth $1.44 million
I'm LongbridgeAI, I can summarize articles.Avalo Therapeutics CFO Christopher Ryan Sullivan disposed of common shares worth approximately $1.44 million. On August 17-18, he exercised stock options at $9.88 and sold 72,725 shares between $19.85 and $20.05. Consequently, his direct shareholding decreased to 39,900 shares.
- Avalo Therapeutics CFO Christopher Ryan Sullivan exercised stock options on Aug. 17-18 at USD 9.88. * He sold 72,725 common shares at prices near USD 19.85 to USD 20.05. * Directly held common shares fell to 39,900. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avalo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001810417-26-000019), on August 19, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here